The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial
Publication
, Journal Article
Berger, M; Timko, NJ; Boykin, PC; Emerson, JM; Woldorff, MG; Wright, MC; Herbert, JT; Moretti, EW; Devinney, MJ; Ryu, D; VanDusen, KW ...
Published in: Alzheimer's & Dementia
December 2024
Duke Scholars
Published In
Alzheimer's & Dementia
DOI
EISSN
1552-5279
ISSN
1552-5260
Publication Date
December 2024
Volume
20
Issue
S8
Publisher
Wiley
Related Subject Headings
- Geriatrics
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Berger, M., Timko, N. J., Boykin, P. C., Emerson, J. M., Woldorff, M. G., Wright, M. C., … Laskowitz, D. T. (2024). The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial. Alzheimer’s & Dementia, 20(S8). https://doi.org/10.1002/alz.095338
Berger, Miles, Noah J. Timko, Piper C. Boykin, Jacqueline M. Emerson, Marty G. Woldorff, Mary Cooter Wright, J Taylor Herbert, et al. “The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial.” Alzheimer’s & Dementia 20, no. S8 (December 2024). https://doi.org/10.1002/alz.095338.
Berger M, Timko NJ, Boykin PC, Emerson JM, Woldorff MG, Wright MC, et al. The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial. Alzheimer’s & Dementia. 2024 Dec;20(S8).
Berger, Miles, et al. “The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial.” Alzheimer’s & Dementia, vol. 20, no. S8, Wiley, Dec. 2024. Crossref, doi:10.1002/alz.095338.
Berger M, Timko NJ, Boykin PC, Emerson JM, Woldorff MG, Wright MC, Herbert JT, Moretti EW, Devinney MJ, Ryu D, VanDusen KW, Bunning T, Hsia BJ, Browndyke JN, Blennow K, Zetterberg H, Laskowitz DT. The Safety, Feasibility and Effect of the APOE Mimetic Peptide CN‐105 on Neuroinflammation and Delirium after Major Non‐cardiac/Non‐neurologic Surgery in Older Adults: Results from the Phase II, Triple Blind, Escalating Dose, MARBLE Randomized Clinical Trial. Alzheimer’s & Dementia. Wiley; 2024 Dec;20(S8).
Published In
Alzheimer's & Dementia
DOI
EISSN
1552-5279
ISSN
1552-5260
Publication Date
December 2024
Volume
20
Issue
S8
Publisher
Wiley
Related Subject Headings
- Geriatrics
- 5202 Biological psychology
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences